"There is no reason anyone would want a computer in their home."
Ken Olsen, chairman and founder of Digital Equipment Corporation ; 1977
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8097757 | Method for preparing (meth)acrylic anhydride The present invention relates to an improved method for preparing (meth)acrylic anhydride (A(M)A2O) by transanhydrification between (meth)acrylic acid and acetic anhydride in the presence of at least one polymerization inhibitor, in which reaction to the ... | 01/17/2012 |
| 8097302 | Electroconductive tin oxide having high mobility and low electron concentration Tin oxide having high mobility and a low electron concentration, and methods for producing layers of the tin oxide layers on a substrate by atmospheric pressure chemical vapor deposition (APCVD) are disclosed. The tin oxide may undoped polycrystalline n-type tin oxi... | 01/17/2012 |
| 8088942 | Process for synthesizing selected organic peroxides The present invention relates to a process for the continuous preparation of selected organic peroxides using plate exchangers having a high heat exchange capacity. ... | 01/03/2012 |
| 8067633 | Method for the synthesis of (meth)acrylic esters catalysed by a polyol titanate The subject of the invention is a method for the synthesis of (meth)acrylic esters by transesterification in the presence of a catalyst corresponding to the formula [(R′O)3Ti]xR″ in which R′ is a linear or branched alkyl radical having fr... | 11/29/2011 |
| 7351839 | Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives This invention provides processes for preparing compounds formula: wherein R is H, alkyl, acyl, aryl, aroyl or —C(O)R′; R′ is alkyl or aryl; R1, R2, R4 and R5 are H, —OH, ... | 04/01/2008 |
| 7179943 | Bicyclic derivatives that modulate voltage-gated potassium channels and methods of use thereof Bicyclic amide derivatives of formula (I) or tautomers or pharmaceutically acceptable salts thereof or both are provided: Also provided are processes for preparing the bicyclic amide derivatives as well as pharma... | 02/20/2007 |
| 7141563 | Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi] indole derivatives This invention provides processes for preparing compounds formula: wherein R is H, alkyl, acyl, aryl, aroyl or —C(O)R′; R′ is alkyl or aryl; R1, R2, R4 and R5 are... | 11/28/2006 |
| 7129237 | [1,4]Diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents Compounds of Formula I or a pharmaceutically acceptable salt thereof are provided: where R1 through R7 are defined herein. The compounds of Formula I are 5HT2c agonists or partial agonists, ... | 10/31/2006 |
| 7098338 | 2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a) quinoxalin-5(6H)one derivatives This invention provides compounds of formula I, wherein R is hydrogen or alkyl of 1–6 carbon atoms; R′ is hydrogen, alkyl of 1–6 carbon atoms, acyl of 2â€... | 08/29/2006 |
| 7071185 | 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents Compounds of Formula I or a pharmaceutically acceptable salt thereof are provided: where R1 through R7 are defined herein. The compounds of Formula I are 5HT2c agonists or partial ago... | 07/04/2006 |
| 7049330 | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents This invention relates to compounds which have activity as 5-HT1A agonists and antagonists which may be useful for the treatment of anxiety, depression, cognitive deficits, and prostate cancer, having the formula | 05/23/2006 |
| 7022716 | Cyclic amine phenyl beta-3 adrenergic receptor agonists This invention provides compounds of Formula I having the structure wherein, R1, R2, R3, R4, R5, T, T1, T2,... | 04/04/2006 |
| 7015242 | Methods for treating hyperactive gastrointestinal motility This invention provides methods for the treatment or inhibition of hyperactive gastrointestinal motility in a mammal utilizing compounds having the formula: where R, and R1 to R6 are described her... | 03/21/2006 |
| 7012089 | [1,4]Diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided: where R1 through R7 are defined herein. The compounds of formula (I) are 5HT2c agonists or partial agonists, and... | 03/14/2006 |
| 6916922 | Process for the preparation of 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta [B] [1,4] diazepino- [6,7,1-hi] indole derivatives This invention provides a process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole derivatives of the general formula: wherein: R is H, alkyl, cycloalkyl, —CH... | 07/12/2005 |
| 6858604 | Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives This invention provides compounds of the formula: wherein R1 and R2 are each, independently, H, alkyl, cycloalkyl, —CH2-cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—... | 02/22/2005 |
| 6831084 | Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity This invention provides compounds and methods using them to provide neuroprotection and prevent or limit processes of neurodegeneration in mammals, including Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, AIDS dementia, retinal disease, diabetic per... | 12/14/2004 |
| 6828324 | Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity This invention provides compounds and methods using them to provide neuroprotection and prevent or limit processes of neurodegeneration in mammals, including Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, AIDS dementia, retinal disease, diabetic per... | 12/07/2004 |
| 6821991 | 2-substituted thiazolidinones as β-3 adrenergic receptor agonists This invention provides compounds of Formula I having the structure wherein: A, X, Y, Z, R1, R2, R3, R4, R5, and R6 a... | 11/23/2004 |
| 6784172 | Processes for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives This invention provides processes for synthesizing compounds of formula I: wherein R is H or alkyl; R1, R2 are H, alkyl, alkoxy, halogen, fluorinated alkyl, —CN, alkyl sulfonamide, alkyl amide, am... | 08/31/2004 |
| 6777407 | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives This invention provides compounds of the formulae: wherein: R1 is hydrogen, —C(O)CH3 or alkyl of 1-6 carbon atoms; R2 and R3 are each, independently, hydrogen, ... | 08/17/2004 |
| 6759405 | Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives This invention provides compounds of formula I having the structure wherein: R1 and R2 are H, alkyl, cycloalkyl, alkoxy, halogen, fluorinated alkyl, —CN, —NH—SO2-alkyl, —SO2 | 07/06/2004 |
| 6750364 | Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine as inhibitors of glutamate transport This invention provides compounds of the formula: wherein X is (CH2)n, O, S, SO, SO2 or CR1R2; n is 1 or 2; R1 and R2 are H, halogen, hydroxy, ... | 06/15/2004 |
| 6743787 | N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists This invention provides compounds of Formula I having the structure wherein R1, R2, R3, R4, W, X, and Y are as defined hereinbefore or a pharmaceutically acceptable salt thereo... | 06/01/2004 |
| 6743796 | Piperazinyl-isatins This invention provides compounds of formula VI wherein Y is hydrogen, methyl, methoxy, methylthio or trifluoromethyl; R is hydrogen, C1-3alkyl or (CH2)nAr; n is 0, 1... | 06/01/2004 |
| 6716998 | Process for synthesis of 2-yl chroman derivatives This invention provides a process for the stereospecific preparation of 2-yl-chroman and -chromene derivatives of the formula: These compounds are useful for the preparation of optically active 2-aminomethyl- and 2-azahe... | 04/06/2004 |
| 6706714 | 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)one derivatives This invention provides compounds of formula I, R is hydrogen or alkyl of 1-6 carbon atoms; R′ is hydrogen, alkyl of 1-6 carbon atoms, acyl of 2-7 carbon atoms, or aroyl; R1, R2, R | 03/16/2004 |
| 6700001 | Process for stereoselective synthesis of 2-hydroxymethyl chromans A process for the stereoselective synthesis of 2-hydroxymethyl-chromans of formula (II) is provided ##STR1## where R, R1, R2 and R3 are as defined herein. The compound of formula (II) is prepared using an optically active ... | 03/02/2004 |
| 6689904 | Bridged tricyclic analogs of 2-(carboxycyclopropyl)glycine This invention provides processes for preparing a group of novel bridged tricyclic compounds having the formula: ##STR1## wherein X is (CH2)n, O, S, SO, SO2 or CR1 R2 ; n is 1 or 2; and R1 ... | 02/10/2004 |
| 6689905 | Stereoisomers of 3-aminotricyclo[2.2.1.0(2.6)]heptane-1,3-dicarboxylic acid This invention provides a process for the preparation of all four stereoisomers of formula I or a pharmaceutically acceptable salt thereof ##STR1## which may be represented by the following structures: ##STR2##... | 02/10/2004 |
| 6667303 | Aryl substituted 1,4-diazepanes and method of use thereof Aryl substituted 1,4-diazepanes are provided such as derivatives of 6-(1,4-diazepan-1-yl)benzo[cd]indol-2(1H)-one, 6-(1,4-diazepan-1-yl)acenaphthylen-1(2H)-one and 5-(1,4-diazepan-1-yl)-2H-naphtho[1,8-cd]isothiazole-1,1-dioxide. Also provided are pha... | 12/23/2003 |
| 6649603 | Cyclylamine sulfonamides as 댣-adrenergic receptor agonists This invention provides compounds of Formula I having the structure ##STR1## wherein R1, R2, R3, W, X, and Z are as defined hereinbefore or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic... | 11/18/2003 |
| 6632824 | Aryl-8-azabicyclo[3.2.1]octanes for the treatment of depression The present invention includes compounds of formula I ##STR1## wherein A, X, n, Ar1, and Ar2 are defined as set forth herein. These compounds may be used to treat depression. The invention also includes formulations containing these ... | 10/14/2003 |
| 6610712 | Aryloxy piperidinyl derivatives for the treatment of depression This invention provides compounds useful in treating serotonin-related central nervous system disorders, including anxiety, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, sleep disorders, sexual dysfunction, alcohol and drug ... | 08/26/2003 |
| 6589986 | Methods of treating anxiety disorders This invention provides methods for treating, preventing or inhibiting anxiety, anxiety-related conditions and phobias in a mammal using compounds of the formula: ##STR1## wherein: R1 is H, alkyl, alkanoyl or the radical Ar; R2 is H ... | 07/08/2003 |
| 6569873 | Azolidines as beta-3 adrenergic receptor agonists This invention provides compounds of Formula I having the structure ##STR1## wherein, A, X, Y, Z, W, R1, R2, R3, R4, R5, and R6 are as defined hereinbefore or a pharmaceutically acceptable salt ... | 05/27/2003 |
| 6537994 | Heterocyclic 댣 adrenergic receptor agonists This invention provides compounds of Formula I having the structure ##STR1## wherein, ##STR2## U, V, and W are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related t... | 03/25/2003 |
| 6514991 | Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists This invention provides compounds of Formula I having the structure ##STR1## and X are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or ... | 02/04/2003 |
| 6509358 | Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists This invention provides compounds of Formula I having the structure ##STR1## and X are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or ... | 01/21/2003 |
| 5922334 | Aqueous nail coating composition The present invention provides an aqueous nail coating composition containing a dispersion of multi-phase polymers. The aqueous nail coating composition has improved resistance to abrasion and chemicals.... | 07/13/1999 |